171 related articles for article (PubMed ID: 28628496)
1. Proton pump inhibitor and selective serotonin reuptake inhibitor therapy for the management of noncardiac chest pain.
Viazis N; Katopodi K; Karamanolis G; Denaxas K; Varytimiadis L; Galanopoulos M; Tsoukali E; Kamberoglou D; Christidou A; Karamanolis DG; Papatheodoridis G; Mantzaris GJ
Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1054-1058. PubMed ID: 28628496
[TBL] [Abstract][Full Text] [Related]
2. [What is the utility of proton pump inhibitor testing in non-cardiac chest pain?].
Huamán JW; Aliaga V; Domenech G; Videla S; Saperas E
Gastroenterol Hepatol; 2014 Oct; 37(8):452-61. PubMed ID: 24725608
[TBL] [Abstract][Full Text] [Related]
3. Selective serotonin reuptake inhibitors for the treatment of hypersensitive esophagus: a randomized, double-blind, placebo-controlled study.
Viazis N; Keyoglou A; Kanellopoulos AK; Karamanolis G; Vlachogiannakos J; Triantafyllou K; Ladas SD; Karamanolis DG
Am J Gastroenterol; 2012 Nov; 107(11):1662-7. PubMed ID: 21625270
[TBL] [Abstract][Full Text] [Related]
4. [Diagnosis of gastroesophageal reflux disease-related noncardiac chest pain].
Zheng J; Du ZM; Chen MH; Lin JK; Hu PJ
Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1390-3. PubMed ID: 18953876
[TBL] [Abstract][Full Text] [Related]
5. Positive predictors for gastroesophageal reflux disease and the therapeutic response to proton-pump inhibitors.
Becker V; Grotz S; Schlag C; Nennstiel S; Beitz A; Haller B; Schmid RM; Meining A; Bajbouj M
World J Gastroenterol; 2014 Apr; 20(14):4017-24. PubMed ID: 24744591
[TBL] [Abstract][Full Text] [Related]
6. Non-cardiac chest pain: prevalence of reflux disease and response to acid suppression in an Asian population.
Mohd H; Qua CS; Wong CH; Azman W; Goh KL
J Gastroenterol Hepatol; 2009 Feb; 24(2):288-93. PubMed ID: 19054255
[TBL] [Abstract][Full Text] [Related]
7. Noncardiac chest pain: diagnosis and management.
Yamasaki T; Fass R
Curr Opin Gastroenterol; 2017 Jul; 33(4):293-300. PubMed ID: 28463855
[TBL] [Abstract][Full Text] [Related]
8. Abnormal GERD parameters on ambulatory pH monitoring predict therapeutic success in noncardiac chest pain.
Kushnir VM; Sayuk GS; Gyawali CP
Am J Gastroenterol; 2010 May; 105(5):1032-8. PubMed ID: 19920808
[TBL] [Abstract][Full Text] [Related]
9. Noncardiac chest pain: update on the diagnosis and management.
Min YW; Rhee PL
Korean J Gastroenterol; 2015 Feb; 65(2):76-84. PubMed ID: 25716709
[TBL] [Abstract][Full Text] [Related]
10. Clinically distinct characteristics in patients younger than 40 years old with non-cardiac chest pain.
Ko SY; Kim SI; Kim JH; Lee JH; Lee KJ; Hong SN; Lee SY; Sung IK; Park HS; Shim CS
J Gastroenterol Hepatol; 2012 Sep; 27(9):1484-9. PubMed ID: 22554344
[TBL] [Abstract][Full Text] [Related]
11. Systematic review: the treatment of noncardiac chest pain.
Hershcovici T; Achem SR; Jha LK; Fass R
Aliment Pharmacol Ther; 2012 Jan; 35(1):5-14. PubMed ID: 22077344
[TBL] [Abstract][Full Text] [Related]
12. Comparison of one-week and two-week empirical trial with a high-dose rabeprazole in non-cardiac chest pain patients.
Kim JH; Sinn DH; Son HJ; Kim JJ; Rhee JC; Rhee PL
J Gastroenterol Hepatol; 2009 Sep; 24(9):1504-9. PubMed ID: 19467139
[TBL] [Abstract][Full Text] [Related]
13. Noncardiac chest pain: gastroesophageal reflux disease.
Oranu AC; Vaezi MF
Med Clin North Am; 2010 Mar; 94(2):233-42. PubMed ID: 20380953
[TBL] [Abstract][Full Text] [Related]
14. Most Patients With Gastroesophageal Reflux Disease Who Failed Proton Pump Inhibitor Therapy Also Have Functional Esophageal Disorders.
Abdallah J; George N; Yamasaki T; Ganocy S; Fass R
Clin Gastroenterol Hepatol; 2019 May; 17(6):1073-1080.e1. PubMed ID: 29913281
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic Response to 20 mg of Esomeprazole Twice Daily in Patients with Gastroesophageal Reflux Disease-related Non-cardiac Chest Pain: An Open-Label Randomized Pilot Study].
Choi JK; Shim HI; Shin CM; Yoon H; Park YS; Kim N; Lee DH
Korean J Gastroenterol; 2020 Jun; 75(6):333-340. PubMed ID: 32581204
[TBL] [Abstract][Full Text] [Related]
16. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of symptom index in identifying gastroesophageal reflux disease-related noncardiac chest pain.
Dekel R; Martinez-Hawthorne SD; Guillen RJ; Fass R
J Clin Gastroenterol; 2004 Jan; 38(1):24-9. PubMed ID: 14679323
[TBL] [Abstract][Full Text] [Related]
18. [Noncardiac chest pain and gastroesophageal reflux disease].
Dimache M; Turcan E; Nătase M
Rev Med Chir Soc Med Nat Iasi; 2010; 114(2):342-8. PubMed ID: 20700964
[TBL] [Abstract][Full Text] [Related]
19. Value of the Gastroesophageal Reflux Disease Questionnaire (GerdQ) in predicting the proton pump inhibitor response in coronary artery disease patients with gastroesophageal reflux-related chest pain.
He S; Liu Y; Chen Y; Tang Y; Xu J; Tang C
Dis Esophagus; 2016 May; 29(4):367-76. PubMed ID: 25721424
[TBL] [Abstract][Full Text] [Related]
20. Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease.
Kahrilas PJ; Hughes N; Howden CW
Gut; 2011 Nov; 60(11):1473-8. PubMed ID: 21508423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
